Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Carsten Detering

Carsten Detering

BioSolveIT Inc., USA

Title: How close are we to predicting binding affinity?

Biography

Biography: Carsten Detering

Abstract

Predicting binding affinity (aka scoring a protein-ligand complex) has been heavily criticized as long as it exists. Sometimes it works on this target, sometimes on another target, but there are few, if any that work consistently well on all targets. One possible explanation and certainly a drawback could be that existing ways of predicting binding affinity (scoring functions) look at favorable interactions, neglecting those interactions that are unmet, which consequently brings into a virtual screening a lot of false positives. BioSolveIT's scoring function Hyde takes on these challenges and is radically different. It is based on pure physico-chemical principles and takes into account hydrogen bonding and the hydrophobic effect. It penalizes missing interactions, wherever a hydrogen bond is not established or a group is misplaced in the active site. This effectively rules out most false positives. There are cases, however where there is hardly coincidence between the experimental and the calculated affinity. Does this mean Hyde does not work as reliably as we expect? We will look at some examples and check who we should trust: our crystal structures or the Hyde scoring function.